Pabianek, M.; Lesiak, A.; Nejc, D.; Kuncman, Ł.; Narbutt, J.; Skibińska, M.; Ciążyńska, M.
Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic. Curr. Oncol. 2022, 29, 7794-7801.
https://doi.org/10.3390/curroncol29100616
AMA Style
Pabianek M, Lesiak A, Nejc D, Kuncman Ł, Narbutt J, Skibińska M, Ciążyńska M.
Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic. Current Oncology. 2022; 29(10):7794-7801.
https://doi.org/10.3390/curroncol29100616
Chicago/Turabian Style
Pabianek, Marta, Aleksandra Lesiak, Dariusz Nejc, Łukasz Kuncman, Joanna Narbutt, Małgorzata Skibińska, and Magdalena Ciążyńska.
2022. "Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic" Current Oncology 29, no. 10: 7794-7801.
https://doi.org/10.3390/curroncol29100616
APA Style
Pabianek, M., Lesiak, A., Nejc, D., Kuncman, Ł., Narbutt, J., Skibińska, M., & Ciążyńska, M.
(2022). Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic. Current Oncology, 29(10), 7794-7801.
https://doi.org/10.3390/curroncol29100616
